Država: Australija
Jezik: engleski
Izvor: Department of Health (Therapeutic Goods Administration)
cetirizine hydrochloride, Quantity: 1 mg/mL
Care Pharmaceuticals Pty Ltd
cetirizine hydrochloride
Oral Liquid, solution
Excipient Ingredients: glycerol; propylene glycol; purified water; methyl hydroxybenzoate; citric acid monohydrate; sorbitol solution (70 per cent) (non-crystallising); propyl hydroxybenzoate; sodium citrate dihydrate; Flavour
Oral
100 mL (PET), 60mL (PET), 200 mL (PET)
Medicine Registered
(S2) Pharmacy Medicine
Seasonal allergic rhinitis: Cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. Symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. , Perennial allergic rhinitis: Cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. Symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. , Chronic idiopathic urticaria: Cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. It significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. As with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.
Visual Identification: A clear colourless solution; Container Type: Bottle; Container Material: PE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2010-11-10